Monkeypox infection: Should we expect changes in its epidemiological and clinical features?
European Journal of Internal Medicine(2023)
摘要
We read with interest the excellent review on the outbreak of monkeypox (MPX) by Patauner et al. [1]. The epidemiological scenario was exhaustively described but referred to a pre-vaccination era. In fact, in August 2022, EMA's Emergency Task Force advised on use of Imvanex/Jynneos against MPX [2]. The Italian Ministry of Health advised pre-exposure vaccination of at-risk individuals identified as men who have sex with men (MSM) having multiple sexual partners, and/or group sex and/or chemsex and/or a recent diagnosis of sexually transmitted infection (STI), irrespective of HIV infection [3].
更多查看译文
关键词
monkeypox infection,epidemiological
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要